Scotts Miracle-Gro stock hits 52-week low at 51.98 USD

Scotts Miracle-Gro Company (SMG) stock experienced a significant drop, trading at a 52-week low of $51.98 USD, marking a 10.77% decrease over the past year. This development, reported by InvestingPro, suggests that the stock is currently undervalued, placing it on the platform's Most Undervalued list. An InvestingPro Tip highlights that the Relative Strength Index (RSI) indicates the stock is in oversold territory, while SMG continues to offer an attractive dividend yield of 5.04%.

Investors are closely watching the situation as the company faces challenges in the current market environment. It is worth noting that SMG has maintained dividend payments for 22 consecutive years, as highlighted by InvestingPro Tips, which tracks 10+ additional insights about the company. For a more comprehensive analysis, a Pro Research Report is available, featuring expert insights on SMG alongside 1,400+ other US equities.

Recently, SMG reported adjusted fiscal third-quarter 2026 earnings of $2.82 per share, surpassing market expectations of $2.48. Revenue for the quarter also met forecasts at $1.17 billion, with sales increasing by 1% compared to the previous year. Following this positive news, SMG raised its full-year adjusted EPS outlook.

In response to the earnings beat, UBS increased its price target for SMG stock from $70 to $78, maintaining a Neutral rating. Stifel also adjusted its price target upward, raising it from $75 to $76 and keeping a Buy rating. Stifel's adjustment was attributed to the earnings upside in the most recent quarter. The fiscal 2026 earnings estimate was increased to $4.44 per share from $4.26 by Stifel.

These recent developments illustrate SCG's recent financial performance and future expectations. This report was produced with AI assistance and reviewed by an editor.